Innovative health app, Holly Health, marks a £1.5 million investment milestone with support from the Women Angels of the North angel syndicate and Leeds-based non-profit NorthInvest.  Promising better help for their 20,000-strong customer base. 

Cydar Medical, a global, cloud-based surgical software company, has completed a £9.3 million Series A funding round from investors including Pembroke VCT, Downing and Greenwood Way Capital.  

SPAIN: Innitius, the Spanish startup focused on improving diagnostics for women's health, has closed a €1.8 million financing round led by Clave Capital and Nara Capital in which most of the investors who had previously backed the company have also joined.  Created in 2017 and headquartered in Bilbao, Innitius aims to improve the health and quality of life of millions of pregnant women and newborns by reducing the impact of pathologies such as preterm birth, induction of birth or cervical cancer in our society.

Evonetix, the synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a USD $24 million financing round, extending its total series B funding to over USD $54 million (circa GB £44 million). This fundraise was led by existing investor Foresite Capital, with Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence also participating in the round.

ITALY: MgShell, a MedTech that aims to revolutionise the treatment of exudative maculopathy, announces the closing of a €500,000 investment round by Bios Line Holding, a company that invests in Life Sciences ventures, Club degli Investitori, one of the leading business angel groups in Italy, and Italian Angels for Biotech, the first Italian angel association exclusively dedicated to Life Sciences. The latter made the investment through the Ersel Group’s Simon Fiduciaria.

Healistic, an innovative HealthTech mobile app and the first pharma-based speedy delivery service in the UK, has announced £1 million in pre-seed funding from leading international investors. 

Powered by the belief that healthcare should be effortless and immediately available to everyone, Healistic is building an all-in-one universal healthcare platform, providing a seamless experience in an asset-light marketplace business model.

EnsiliTech, the award-winning biopharmaceuticals company has raised £1.2 million in pre-seed funding to aid the development of a pioneering refrigeration-free approach to transporting vaccines and other materials.

Hilltop Leaf, the company behind one of the UK’s first medicinal cannabis cultivation and production facilities, has raised £2m from Traditum Private Equity and private investors.  The funding will enable the company to make its first commercial sales and scale its infrastructure to become one of the largest UK producers of medicinal cannabis products for the specialist prescription market. 

QV Bioelectronics, creators of an innovative surgically implanted Electric Field Therapy (EFT) device for the treatment of brain tumours – has secured £2m in Pre-Series A funding from new and existing leading deep tech investors. The round was led by the Science Angel Syndicate and Fink Family Office with participation from Northern Gritstone, Elbow Beach Capital, and existing investors SOSV and Catapult Ventures.

Oxford Innovation EIS Growth Fund and OION Angels invest 14% of Qkine’s latest £4.3 million fund raise which was co-led by Parkwalk Advisors Ltd and Downing Ventures.

Two leading doctors who developed a new health coaching platform after the untimely death of a colleague have raised over £1m in a funding round led by private equity firm Traditum and backed by angel investors.  The funding will enable physiologist and serial entrepreneur Dr Michael Stein and Oxford University’s Professor Chris Butler to develop their Added Health platform further and roll it out to a wider audience.

Jellagen, an innovative biotech company and leader in biomaterials derived from jellyfish, has closed a successful £8.7m Series A equity investment round.